Comparative bioavailability of two different diclofenac formulations in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 11, 1999, Pages 920-924

  Silva, Lara Cristina ^a   Simões, Inácia Gonçalves ^c   Lerner, Federico Ezcquiel ^a,b   Belém, Gina Rodrigues ^c   De Moracs, Maria Elizabete Amaral ^c   De Nucci, Gilberto ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

CAS 15307 86 5; Cataflam ; Diclofenac, bioequivalence, pharmacokinetics, volunteers

Indexed keywords

DICLOFENAC; DICLOFENAC POTASSIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0345268636     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300527     Document Type: Article

References (28)

1. Skoutakis, V. A., Carter, C. A., Mickle, T. R., Drug Intell. Clin. Pharm. 22, 850 (1988)
2. Scholer, D. W., Ku, E. C., Boettcher, I., Am. J. Med. 80, 34 (1986)
3. Ku, E. C., Lee, W., Kothari., H. V., Am. J. Med. 80, 18 (1986)
4. Zuckner, J., Am. J. Med. 80, 39 (1986)
5. Kurowski, M., Menninger, H., Pauli, E., Int. J. Clin. Pharmacol. Ther. 32, 433 (1994)
6. Kovarik, J. M., Kurki, P., Mueller., E., J. Rheumatol. 23, 2033 (1996)
7. Kovarik, J. M., Mueller, E. A., Gerbeau, C., J. Clin. Pharmacol. 37, 336 (1997)
8. Altman, R., Am. J. Med. 80, 48 (1986)
9. Bakshi, R., Br. J. Clin. Pract. 50, 294 (1996)
10. Calabro, J. J., Am. J. Med. 80, 58 (1986)
11. Small, R. E., Clin. Pharm. 8, 545 (1989)
12. Kantor, T. G., Am. J. Med. 80, 64 (1986)
13. Bahamonde, L. A., Saavedra, H., J. Int. Med. Res. 18, 104 (1990)
14. Bakshi, R., Frenkel, G., Dietlein., G. A., J. Clin. Pharmacol. 34, 225 (1994)
15. Ahlstrom, U., Bakshi, R., Nilsson, P., Eur. J. Clin. Pharmacol. 44, 587 (1993)
16. Marchini, M., Tozzi, L., Bakshi, R., Int. J. Clin. Pharmacol. Ther. Toxicol. 33, 491 (1995)
17. Soll, A. H., Weistein., W. M., Kurata, J., Ann. Intern. Med. 114, 307 (1991)
18. Todd, P. A., Sorkin, E. M., Drugs 35, 244 (1988)
19. Riess, W, Stierlin, H., Degen, P., Scand. J. Rheumatol Suppl. 22, 17 (1978)
20. Willis, J. V., Kendall, M. J., Flinn, R. M., Eur. J. Clin. Pharmacol. 16, 405 (1979)
21. Menasse, R., Hedwall, P. R., Kraetz, J., Scand. J. Rheumatol. Suppl. 22, 5 (1978)
22. Davies, N. M., Anderson, K. E., Clin. Pharmacokinet. 33, 184 (1997)
23. Santos, S. R. C. J., Donzella, H., Bertoline, M. A., Braz. J. Med. Biol. Res. 25, 125 (1992)
24. Mendes, G. B. B., Franco, L. M., Moreno, R. A., Int. J. Clin. Pharmacol. Ther. Toxicol. 32, 131 (1994)
25. Food and Drug Administration. Fed Register 320, 154 (1985)
26. Marzo, A., Arzneim.-Forsch./Drug Res. 45 (I), 109 (1995)
27. Salmonson, T., Bioavailability, Bioequivalence and Pharmacokinetics, International Conference of F.I.P. Bio-International 96, Tokyo/Japan, pp. 16-19 (1996)
28. Hauschke, D., Steinijans, V. W., Diletti, E., Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 72 (1990)